483 Aurobindo Pharma Limited - Unit IV Dec 2018

483 Aurobindo Pharma Limited - Unit IV Dec 2018

Atul Agrawal FDA, Jose Cruz Gonzalez FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma Limited - Unit IV - Medak District, Hyderabad, India facility and issued inspectional observations (via FDA 483) on 14 Dec 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Dec 2018
  • Location: Medak District, Hyderabad, India
  • FEI: 3008461619
Add To Cart